Company
Orixha
- Biotech
- Headquarters:
- Saint Cyr Au Mont D'Or
Description
Orixha develops a proprietary Total Liquid Ventilation technology called LuncoLive for intensivists and critical care professionals to provide respiratory support to intubated and comatose patients.
Related
AerogenAerogen makes nebuliser systems that deliver aerosol medications.
ALK-Abelló A/SDevelops allergy treatments and related solutions for people with respiratory allergies, serving healthcare providers and patients through…
Vertiv ($VRT)Builds critical digital infrastructure for power, cooling, IT, and services, including liquid cooling and thermal management for…
miDiagnosticsDevelops silicon chip–based molecular diagnostic tests and portable readers for fast, accurate results to support healthcare professionals…
BD Medical SandyDevelops medical products, connected care technologies, biopharmaceutical systems, and clinical services for healthcare professionals…
Confo TherapeuticsConfo Therapeutics develops small molecule and antibody-based therapeutics using proprietary GPCR-targeting technology for metabolic,…
TheratechnicaTheratechnica develops medical technology solutions, including VR, AR, medical apps, and AI tools.
NETRIS PHARMA SASNETRIS Pharma develops first-in-class therapeutics targeting Netrin-1 to overcome resistance in oncology, providing treatments to patients…
Archangel HealthProvide infrastructure software that powers medical artificial intelligence systems, helping healthcare teams operate models for clinical…
Neuromod DevicesDevelops the Lenire bimodal neuromodulation tinnitus treatment device for clinicians and patients seeking tinnitus care across Europe and…
FIRE1Builds heart-failure care tools for restoring patients' everyday health and function; used by clinicians and patients managing heart…
Medtronic Robotics ($MDT)Offers a robotic-assisted surgery system, along with patient services and customer care, for healthcare professionals and patients involved…